Drug
Deramiocel
Deramiocel: highest development phase Phase 3, developed by Capricor Inc.. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Capricor Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Deramiocel NCT05126758 | Phase 3 | Muscular Dystrophies |
| Deramiocel (CAP-1002) NCT04428476 | Phase 2 | Duchenne Muscular Dystrophy |
Latest
No recent events.
Follow Deramiocel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.